Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001228924-23-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-09-01 | MLAB | Owens Gary M | Pres, CEO | M - OptEx | $136.42 | +2,000 | 32.0K | +7% | +$272.8K |
| D | 2023-09-05 | 2023-09-01 | MLAB | Owens Gary M | Pres, CEO | S - Sale+OE | $142.82 | -2,000 | 30.0K | -6% | -$285.6K |
| D | 2023-09-05 | 2023-09-01 | MLAB | Owens Gary M | Pres, CEO | X - OptEx | $0.00 | -2,000 | 99.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 2,000 | $136.42 | 32,032 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | S | D | 2,000 | $142.82 | 30,032 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on May 30, 2023 |
| 3 | Derivative | Non Qualified Stock Options | 2023-09-01 | X | D | 2,000 | $0.00 | 99,769 | D | $136.42 · 2018-09-01 to 2023-09-01 | 2,000 Common Stock | (F1) 1/5 exercisable on each anniversary date of the 09-01-2017 grant date |